Report of a New Method Used to Identify the Bacteria Present in a Human Colon Biopsy Sample
NCT ID: NCT00882752
Last Updated: 2011-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1 participants
OBSERVATIONAL
2008-01-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Different Methods for the Analysis of Gut Microbiome Composition
NCT04082221
Validation of Breath Tests in Diagnosing Small Bowel Bacterial Overgrowth
NCT00872092
Role of Gut Microbiota in the Pathophysiology of Aseptic Abscesses
NCT05537909
Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections
NCT00860587
Role of Faecal Calprotectin in Patients With Abdominal Pain
NCT05795985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ulcerative colitius
The method used to identify the microbes in the sample was chosen because it had the potential to provide more exhaustive identification of the bacteria present in the sample as compared to culturing methodology.
molecular analysis
bowel disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
molecular analysis
bowel disease
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>= 18 years old
* Female
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southwest Regional Wound Care Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Randall Wolcott
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Randall Wolcott, MD
Role: PRINCIPAL_INVESTIGATOR
Southwest Regional Wound Care
Randall Wolcott, MD
Role: PRINCIPAL_INVESTIGATOR
Southwest Regional Wound Care Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
56-RW-009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.